Death (any cause · adults undergoing maintenance dialysis
It is very uncertain whether any exercise changes death (any cause compared with no exercise or placebo exercise (very low certainty).
1 finding from 1 review
Death (any cause) · people IgA nephropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · adults with early (stage 1 to 3) non‐diabetic CKD
Angiotensin‐converting enzyme inhibitors showed no clear difference in death (any cause) compared with placebo (low certainty).
1 finding from 1 review
Death (any cause) · adults with early (stage 1 to 3) non‐diabetic CKD
1 finding from 1 review
Death (any cause) · adults undergoing maintenance dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · adults undergoing maintenance dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · adults undergoing maintenance dialysis
It is very uncertain whether aerobic exercise changes death (any cause) compared with no exercise or placebo exercise (very low certainty).
1 finding from 1 review
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (3.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (1.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · people with chronic kidney disease requiring dialysis
Aldosterone antagonists (spironolactone or eplerenone) probably leads to lower death (any cause) compared with control (placebo or standard care) (moderate certainty).
1 finding from 1 review
Death (any cause) · pre‐existing and new‐onset diabetes in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · pre‐existing and new‐onset diabetes in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · pre‐existing and new‐onset diabetes in kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · heart failure with chronic kidney disease
ACUTE: Serelaxin showed no clear difference in death (any cause) compared with placebo (low certainty).
1 finding from 1 review
Death (any cause) · people with CKD (including haemodialysis)
It is very uncertain whether potassium binder changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) ( · heart failure with chronic kidney disease
CHRONIC: ACEi or ARB showed no clear difference in death (any cause) ( compared with placebo (low certainty).
1 finding from 1 review
Death (any cause) ( · heart failure with chronic kidney disease
CHRONIC: Beta‐blockers probably leads to lower death (any cause) ( compared with placebo (moderate certainty).
1 finding from 1 review
Death (any cause) ( · heart failure with chronic kidney disease
It is very uncertain whether CHRONIC: Aldosterone antagonists changes death (any cause) ( compared with placebo (very low certainty).
1 finding from 1 review